Alan Chramiec

Alan Chramiec

Auto-generated profile, based on publicly available information

Alan Chramiec

Department of Biomedical Engineering, Columbia University, New York, NY 10025, USA

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
4 September 2020 in Lab on a Chip
Verified
Journal Article
Closed access
PDF file
ACAlan Chramiec
Alan Chramiec
DTDiogo Teles
Diogo Teles
KYKeith Yeager
Keith Yeager
AMAlessandro Marturano-Kruik
Alessandro Marturano-Kruik
JPJoseph Pak
Joseph Pak
Gordana Vunjak-NovakovicGordana Vunjak-Novakovic
Gordana Vunjak-Novakovic
In a novel, integrated platform, integration of human bone tumor and cardiac tissues improved predictive accuracy of linsitinib efficacy and safety. This platform mimicked clinical trial results, unlike other pre-clinical models.

19 August 2026 in Science Translational Medicine
Verified
Journal Article
Closed access
ACAlan G. Chramiec
Alan G. Chramiec
IBIlaria Baldassarri
Ilaria Baldassarri
EÖEce Öztürk
Ece Öztürk
DTDaniel Naveed Tavakol
Daniel Naveed Tavakol
MWMiranda C. Wang
Miranda C. Wang
Gordana Vunjak-NovakovicGordana Vunjak-Novakovic
Gordana Vunjak-Novakovic
For metastatic colonization to occur, disseminated tumor cells must survive, adapt to, and remodel distant microenvironments in an organ-specific manner. We established a human multitissue model of cancer spread, with engineered bone and lung linked by vascular flow containing circulating cancer cells. Parental MDA-MB-231 cells extravasated toward both tissues, remodeled their niches, and acquired transcriptional programs reflecting adaptation to the local microenvironment, particularly upon homing to bone. Tissue-specific colonization by the bone- and lung-tropic MDA-MB-231 derivatives was quantified in independently perfused bone or lung platforms. Consistent with in vivo behavior, bone-tropic cells showed stronger bone colonization than lung-tropic cells and induced more pronounced osteolysis. In contrast, lung-tropic cells caused greater epithelial disruption in lung tissue and only modest colonization of bone. Distinct patterns of tissue colonization and secreted factors demonstrate that this device recapitulates key features of organ-specific metastasis observed in vivo for this family of cell lines.

1 September 2021 in Annals of Oncology
Verified
Journal Article
Open access
PDF file
ACA. Chramiec
A. Chramiec
EÖE. Öztürk
E. Öztürk
MWM. Wang
M. Wang
KRK. Ronaldson-Bouchard
K. Ronaldson-Bouchard
DTD.N. Tavakol
D.N. Tavakol
Gordana Vunjak-NovakovicGordana Vunjak-Novakovic
Gordana Vunjak-Novakovic
The 5-year survival rates for metastatic breast cancer are stuck at <30%. The plateauing of progress suggests the need for improved, dynamic, 3D, and human models of this multi-tissue process. Breast cancer metastasis also tends to have a subtype dependent organotropism. Here we show that using a novel organs-on-a-chip platform we have been able to recapitulate the multiple stages of both multi-tissue and tissue-specific breast cancer metastasis for the first time in an entirely human in vitro model.